Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)

[1]  J. Laman,et al.  CD40-CD40L interactions in atherosclerosis. , 1997, Immunology today.

[2]  H. Weiner,et al.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Franciscus Kroese,et al.  The handbook of experimental immunology. , 1997 .

[4]  H. McFarland,et al.  Complexities in the Treatment of Autoimmune Disease , 1996, Science.

[5]  S. Hauser,et al.  Late Complications of Immune Deviation Therapy in a Nonhuman Primate , 1996, Science.

[6]  C. Janeway,et al.  Requirement for CD40 Ligand in Costimulation Induction, T Cell Activation, and Experimental Allergic Encephalomyelitis , 1996, Science.

[7]  R. Flavell,et al.  A central role of CD40 ligand in the regulation of CD4+ T-cell responses. , 1996, Immunology today.

[8]  M. Crow,et al.  Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. , 1996, The Journal of clinical investigation.

[9]  J. Ceuppens,et al.  Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin‐12 for interferon‐γ production , 1996, European journal of immunology.

[10]  M. W. Flye,et al.  Inhibition by CTLA4Ig of experimental allergic encephalomyelitis. , 1996, Journal of immunology.

[11]  H. Nariuchi,et al.  Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. , 1996, Journal of immunology.

[12]  R. Ramsey‐Goldman,et al.  Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. , 1996, The Journal of clinical investigation.

[13]  A. Aruffo,et al.  CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Sun,et al.  Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. , 1996, Immunity.

[15]  T. Horii,et al.  Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. , 1996, Immunity.

[16]  S. Reed,et al.  CD40 ligand is required for protective cell-mediated immunity to Leishmania major. , 1996, Immunity.

[17]  M. Croft,et al.  Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals. , 1996, International immunology.

[18]  K. Mohler,et al.  CD40/CD40 ligand interactions are required for T cell‐dependent production of interleukin‐12 by mouse macrophages , 1996, European journal of immunology.

[19]  E Stuber,et al.  Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion , 1996, The Journal of experimental medicine.

[20]  J. Suttles,et al.  Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. , 1996, Journal of immunology.

[21]  J. Banchereau,et al.  CD40-CD40 ligand: a multifunctional receptor-ligand pair. , 1996, Advances in immunology.

[22]  O. Bagasra,et al.  Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Gray,et al.  CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.

[24]  R. Flavell,et al.  Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.

[25]  N. Letvin,et al.  Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. , 1995, The Journal of clinical investigation.

[26]  W. Liles,et al.  Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. , 1995, The Journal of infectious diseases.

[27]  Nitin J. Karandikar,et al.  Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. , 1995, Immunity.

[28]  D. Hafler,et al.  Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions , 1995, The Journal of experimental medicine.

[29]  P. Kiener,et al.  Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. , 1995, Journal of immunology.

[30]  P. Linsley,et al.  CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. , 1995, Journal of immunology.

[31]  Hans Lassmann,et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.

[32]  C. June,et al.  Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. , 1995, The Journal of clinical investigation.

[33]  R. Flavell,et al.  An essential role for gp39, the ligand for CD40, in thymic selection , 1995, The Journal of experimental medicine.

[34]  A. Harmsen,et al.  CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. , 1995, Journal of immunology.

[35]  R. Swanborg.  Animal models of human disease : experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease , 1995 .

[36]  P. Kiener,et al.  Expression of functional CD40 by vascular endothelial cells , 1995, The Journal of experimental medicine.

[37]  C. Polman,et al.  The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis , 1995, Nature.

[38]  M. Woodroofe.  Cytokine production in the central nervous system , 1995, Neurology.

[39]  C. Brosnan,et al.  Cytokine localization in multiple sclerosis lesions , 1995, Neurology.

[40]  R. Karr,et al.  Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. , 1995, The Journal of clinical investigation.

[41]  J. Pober,et al.  CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Steffen Jung,et al.  Macrophages in T cell line‐mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats , 1995, Clinical and experimental immunology.

[43]  N. Letvin,et al.  Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis , 1995, Annals of neurology.

[44]  T. Olsson.  Critical Influences of the Cytokine Orchestration on the Outcome of Myelin Antigen‐Specific T‐Cell Autoimmunity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis , 1995, Immunological reviews.

[45]  C. Maliszewski,et al.  Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction , 1995, European journal of immunology.

[46]  H. McFarland.  The multiple sclerosis lesion , 1995, Annals of neurology.

[47]  C. Raine,et al.  The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.

[48]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[49]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[50]  C. Mohan,et al.  Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. , 1995, Journal of immunology.

[51]  P. Albert,et al.  Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. , 1995, Journal of immunology.

[52]  P. Linsley,et al.  Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responses , 1995, European journal of immunology.

[53]  D. Lawrence,et al.  Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1 , 1995, European journal of immunology.

[54]  C. Polman,et al.  The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. , 1995, Nature.

[55]  小島 公一.  Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia , 1995 .

[56]  E Claassen,et al.  Detection of human cytokines in situ using antibody and probe based methods. , 1995, Journal of immunological methods.

[57]  J. Suttles,et al.  Role of the CD40‐CD40 ligand interaction in CD4+ T cell contact‐dependent activation of monocyte interleukin‐1 synthesis , 1994, European journal of immunology.

[58]  H. McFarland.  Significance of autoreactive T cells in diseases such as multiple sclerosis using an innovative primate model. , 1994, The Journal of clinical investigation.

[59]  R. Ferrante,et al.  In healthy primates, circulating autoreactive T cells mediate autoimmune disease. , 1994, The Journal of clinical investigation.

[60]  H. Lassmann,et al.  Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia , 1994, The Journal of experimental medicine.

[61]  J. V. van Noort,et al.  Fractionation of central nervous system myelin proteins by reversed-phase high-performance liquid chromatography. , 1994, Journal of chromatography. B, Biomedical applications.

[62]  G. Inghirami,et al.  CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. , 1994, Journal of immunology.

[63]  M. Cuzner,et al.  Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. , 1993, Cytokine.

[64]  A. Aruffo,et al.  Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. , 1993, Science.

[65]  W. Fanslow,et al.  CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.

[66]  J. Kwekkeboom,et al.  CD40 plays an essential role in the activation of human B cells by murine EL4B5 cells. , 1993, Immunology.

[67]  B. Engelhardt,et al.  Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody , 1992, Journal of Neuroimmunology.

[68]  H. Lassmann,et al.  Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG) , 1987, Journal of Neuroimmunology.

[69]  Dr. med. Hans Lassmann.  Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 1983, Schriftenreihe Neurologie / Neurology Series.